• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼肌型重症肌无力与全身型重症肌无力外周血调节性T细胞及其功能亚群的比较

Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis.

作者信息

Rao Jie, Li Siyu, Wang Xinyu, Cheng Qi, Ji Yu, Fu Wenwen, Huang Hui, Shi Ling, Wu Xiaorong

机构信息

Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Front Med (Lausanne). 2022 Jun 9;9:851808. doi: 10.3389/fmed.2022.851808. eCollection 2022.

DOI:10.3389/fmed.2022.851808
PMID:35755064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9218215/
Abstract

PURPOSE

This study aims to discuss the function mechanism of regulatory T cells and its subsets in the pathogenic process of myasthenia gravis by contracting the activation levels of those cells in peripheral blood among healthy people, patients with ocular myasthenia gravis (oMG) and patients with generalized myasthenia gravis (gMG).

METHOD

Healthy people, newly diagnosed oMG patients, and gMG patients were enrolled in this study. The percentage of the CD3CD4CD25 Treg cells, CD3CD4CD25Foxp3 Treg cells, CD3CD4CD25Foxp3 CD45RAaTreg cells, CD3CD4CD25Foxp3CD45RAn-sTreg cells, and CD3CD4CD25 Foxp3CD45RArTreg cells in the peripheral blood were examined by flow cytometry. And then analyzed the differences of Treg cells and its subsets among the study members.

RESULTS

The percentage of the CD4CD25Treg cells in the peripheral blood of oMG patients and gMG patients were both lower than that of healthy people ( < 0.05), the percentage of patients with oMG had no distinct difference with that of patients with gMG ( = 0.475), however. Also, the percentage of CD3CD4CD25Foxp3Treg cells in the oMG and gMG patients' group were both lower than that of healthy group. And the percentage of CD25Foxp3Treg cells in the peripheral blood of patients with oMG and healthy people were both higher than that of patients with gMG ( < 0.05). The percentage of rTreg in the CD3CD4CD25Treg of the peripheral blood for both gMG and oMG patients' group were lower than healthy group ( < 0.05), but there was no statistical significance between the oMG and gMG patients' group ( = 0.232). The percentage of the aTreg cells in the CD3CD4CD25Treg cells of the peripheral blood for the oMG patients was higher than that of gMG patients ( < 0.05), but both of them were lower than healthy group ( < 0.05). The percentage of n-sTreg cells in the peripheral blood descended among the gMG patients' group, oMG patients' group, and healthy group ( < 0.05).

CONCLUSION

The changes in the number and function of Treg cells and its subsets can cause the impairment of negative immune regulation, which may mediate the triggering of oMG and its progression to gMG.

摘要

目的

本研究旨在通过对比健康人、眼肌型重症肌无力(oMG)患者和全身型重症肌无力(gMG)患者外周血中调节性T细胞及其亚群的激活水平,探讨其在重症肌无力发病过程中的作用机制。

方法

本研究纳入健康人、新诊断的oMG患者和gMG患者。采用流式细胞术检测外周血中CD3CD4CD25 Treg细胞、CD3CD4CD25Foxp3 Treg细胞、CD3CD4CD25Foxp3 CD45RAaTreg细胞、CD3CD4CD25Foxp3CD45RAn-sTreg细胞和CD3CD4CD25 Foxp3CD45RArTreg细胞的百分比。然后分析研究对象中Treg细胞及其亚群的差异。

结果

oMG患者和gMG患者外周血中CD4CD25Treg细胞的百分比均低于健康人(P<0.05),然而,oMG患者与gMG患者的百分比无明显差异(P = 0.475)。此外,oMG和gMG患者组中CD3CD4CD25Foxp3Treg细胞的百分比均低于健康组。oMG患者和健康人外周血中CD25Foxp3Treg细胞的百分比均高于gMG患者(P<0.05)。gMG和oMG患者组外周血CD3CD4CD25Treg中rTreg的百分比均低于健康组(P<0.05),但oMG和gMG患者组之间无统计学意义(P = 0.232)。oMG患者外周血CD3CD4CD25Treg细胞中aTreg细胞的百分比高于gMG患者(P<0.05),但两者均低于健康组(P<0.05)。gMG患者组、oMG患者组和健康组外周血中n-sTreg细胞的百分比均下降(P<0.05)。

结论

Treg细胞及其亚群数量和功能的变化可导致负性免疫调节受损,这可能介导oMG的触发及其向gMG的进展。

相似文献

1
Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis.眼肌型重症肌无力与全身型重症肌无力外周血调节性T细胞及其功能亚群的比较
Front Med (Lausanne). 2022 Jun 9;9:851808. doi: 10.3389/fmed.2022.851808. eCollection 2022.
2
Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.比较眼肌型和全身型重症肌无力患者外周血 B 细胞亚群比值和 B 细胞相关细胞因子水平。
Int Immunopharmacol. 2020 Mar;80:106130. doi: 10.1016/j.intimp.2019.106130. Epub 2020 Jan 21.
3
Different molecular expression in thymoma with ocular or generalized myasthenia gravis.胸腺瘤伴眼肌型或全身型重症肌无力的不同分子表达。
J Neurol Sci. 2012 Feb 15;313(1-2):27-31. doi: 10.1016/j.jns.2011.09.037. Epub 2011 Oct 13.
4
FoxP3 Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines.重症肌无力中FoxP3调节性1型细胞及其与抗乙酰胆碱受体抗体和免疫调节细胞因子的关系。
Front Neurol. 2021 Dec 17;12:755356. doi: 10.3389/fneur.2021.755356. eCollection 2021.
5
Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.免疫分子 CD25 和 CXCL13 的表达与重症肌无力的临床严重程度相关。
J Mol Neurosci. 2013 Jun;50(2):317-23. doi: 10.1007/s12031-013-9976-9. Epub 2013 Feb 10.
6
Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.眼肌型重症肌无力患者的眼肌抗体:乙酰胆碱受体抗体阴性患者眼肌炎症的可能机制。
Clin Immunol Immunopathol. 1998 Jun;87(3):276-81. doi: 10.1006/clin.1998.4536.
7
Study of serum exosome miRNA as a biomarker for early onset adult ouclar myastthenia gravis.血清外泌体 miRNA 作为早发型成人眼肌型重症肌无力生物标志物的研究。
Gene. 2024 Feb 20;896:148034. doi: 10.1016/j.gene.2023.148034. Epub 2023 Nov 25.
8
Multiple sclerosis patients have reduced resting and increased activated CD4CD25FOXP3T regulatory cells.多发性硬化症患者的静止 CD4CD25FOXP3T 调节性细胞减少,激活的 CD4CD25FOXP3T 调节性细胞增加。
Sci Rep. 2021 May 18;11(1):10476. doi: 10.1038/s41598-021-88448-5.
9
Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.成人眼肌型重症肌无力转化:中国单中心回顾性分析。
Eur Neurol. 2020;83(2):182-188. doi: 10.1159/000507853. Epub 2020 Jun 11.
10
Phenotypes of regulatory T cells in different stages of COPD.COPD 不同阶段调节性 T 细胞的表型。
Int Immunopharmacol. 2024 Oct 25;140:112765. doi: 10.1016/j.intimp.2024.112765. Epub 2024 Jul 30.

引用本文的文献

1
Regulatory T Cell and T Helper 17 Cell Imbalance in Patients with Unexplained Infertility.不明原因不孕症患者调节性T细胞与辅助性T细胞17失衡
Int J Womens Health. 2024 May 31;16:1033-1040. doi: 10.2147/IJWH.S455733. eCollection 2024.
2
MicroRNA‑155‑5p affects regulatory T cell activation and immunosuppressive function by targeting BCL10 in myasthenia gravis.微小RNA-155-5p通过靶向重症肌无力中的BCL10影响调节性T细胞活化和免疫抑制功能。
Exp Ther Med. 2023 Nov 9;27(1):6. doi: 10.3892/etm.2023.12293. eCollection 2024 Jan.

本文引用的文献

1
Editorial: Advances in Autoimmune Myasthenia Gravis.社论:自身免疫性重症肌无力的进展
Front Immunol. 2020 Aug 28;11:1688. doi: 10.3389/fimmu.2020.01688. eCollection 2020.
2
Reduced CD4 CD25 CD45RA Foxp3 activated regulatory T cells and its association with acute rejection in patients with kidney transplantation.肾移植患者中 CD4 CD25 CD45RA Foxp3 激活调节性 T 细胞减少及其与急性排斥反应的关系。
Transpl Immunol. 2020 Jun;60:101290. doi: 10.1016/j.trim.2020.101290. Epub 2020 Mar 30.
3
Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
比较眼肌型和全身型重症肌无力患者外周血 B 细胞亚群比值和 B 细胞相关细胞因子水平。
Int Immunopharmacol. 2020 Mar;80:106130. doi: 10.1016/j.intimp.2019.106130. Epub 2020 Jan 21.
4
IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.系统性红斑狼疮中的 IL-10 产生调节性和辅助性 T 细胞。
Semin Immunol. 2019 Aug;44:101330. doi: 10.1016/j.smim.2019.101330. Epub 2019 Nov 15.
5
The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients.调节性 T 细胞亚群改变对初诊原发性免疫性血小板减少症患者糖皮质激素治疗的预测价值。
Thromb Res. 2019 Sep;181:10-16. doi: 10.1016/j.thromres.2019.07.001. Epub 2019 Jul 2.
6
OMIP-053: Identification, Classification, and Isolation of Major FoxP3 Expressing Human CD4 Treg Subsets.OMIP-053:人 CD4+Treg 亚群的主要 FoxP3 表达细胞的鉴定、分类和分离。
Cytometry A. 2019 Mar;95(3):264-267. doi: 10.1002/cyto.a.23704. Epub 2018 Dec 24.
7
Myasthenia gravis: from autoantibodies to therapy.重症肌无力:从自身抗体到治疗。
Curr Opin Neurol. 2018 Oct;31(5):517-525. doi: 10.1097/WCO.0000000000000596.
8
Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.靶向调节性 T 细胞治疗系统性红斑狼疮患者。
Front Immunol. 2018 Apr 17;9:786. doi: 10.3389/fimmu.2018.00786. eCollection 2018.
9
Revealing the specificity of regulatory T cells in murine autoimmune diabetes.揭示调节性 T 细胞在鼠自身免疫性糖尿病中的特异性。
Proc Natl Acad Sci U S A. 2018 May 15;115(20):5265-5270. doi: 10.1073/pnas.1715590115. Epub 2018 Apr 30.
10
Transcriptional regulation and development of regulatory T cells.调节性 T 细胞的转录调控与发育。
Exp Mol Med. 2018 Mar 9;50(3):e456. doi: 10.1038/emm.2017.313.